Kei Takedomi

Years Active: 2021-2022
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Toru Iijima, Makoto Katoh, Kei Takedomi, Yasuo Yamamoto, Hidenori Akatsuka, Naritoshi Shirata, Akito Nishi, Misae Takakuwa, Yoshinori Watanabe, Hitomi Munakata, Naomi Koyama, Tomoko Ikeda, Taku Iguchi, Harutoshi Kato, Kohei Kikkawa, Takayuki Kawaguchi
Discovery of Apararenone (MT-3995) as a Highly Selective, Potent, and Novel Nonsteroidal Mineralocorticoid Receptor Antagonist. Journal of medicinal chemistry 65 (12) (2022)
Daisuke Iijima, Hiroshi Sugama, Yoichi Takahashi, Miki Hirai, Yuko Togashi, Jianshu Xie, Jingkang Shen, Ying Ke, Hidenori Akatsuka, Takayuki Kawaguchi, Kei Takedomi, Akiko Kashima, Masashi Nishio, Yosuke Inui, Hikaru Yoneda, Guangxin Xia, Toru Iijima
Discovery of SPH3127: A Novel, Highly Potent, and Orally Active Direct Renin Inhibitor. Journal of medicinal chemistry 65 (16) (2022)
Daisuke Iijima, Hiroshi Sugama, Nobumasa Awai, Yoichi Takahashi, Yuko Togashi, Tohru Takebe, Jianshu Xie, Jingkang Shen, Ying Ke, Hidenori Akatsuka, Takayuki Kawaguchi, Kei Takedomi, Akiko Kashima, Masashi Nishio, Yosuke Inui, Hikaru Yoneda, Guangxin Xia, Toru Iijima
Discovery of Novel 2-Carbamoyl Morpholine Derivatives as Highly Potent and Orally Active Direct Renin Inhibitors. ACS medicinal chemistry letters 13 (8) (2022)
Kei Takedomi, Masateru Ohta, Toru Ekimoto, Mitsunori Ikeguchi
Effect of Water Molecules on the Activating S810L Mutation of the Mineralocorticoid Receptor. Journal of chemical information and modeling 61 (7) (2021)

Kei Takedomi.css-eqlu8i{font-size:small;padding-left:4px;}